Human IGFBP-2 PharmaGenie ELISA Kit (SBRS0704)

Quantitative measurement of human Insulin-like Growth Factor Binding Protein 2 (IGFBP-2) in cell culture supernatants, plasma-derived samples, and serum fractions supports oncology, endocrinology, and metabolic disease research workflows. Built for research use only, this Assay Genie kit arrives configured for 96 assays per plate, with each well pre-coated with capture antibody specific to IGFBP-2 to bind analyte from prepared samples. Following incubation with biotinylated detection antibody and streptavidin-HRP conjugate, a chromogenic substrate develops a measurable colorimetric signal proportional to IGFBP-2 concentration. Researchers studying prostate, breast, and ovarian cancer, where circulating IGFBP-2 levels are frequently elevated, rely on this format to monitor biomarker trends in patient-derived samples and in conditioned media from relevant cell models. Standard laboratory ELISA equipment including a microplate reader is sufficient for endpoint quantification. Reagents are supplied ready-to-use or in concentrated form depending on the component, and the included protocol recommends storage at 4 degrees C for short-term use, with longer-term component storage as detailed in the manual. Useful for in vitro experiments, the kit provides a reproducible route to quantify an IGF-axis protein that influences glucose homeostasis, cell proliferation, and tumor microenvironment signaling.